Comparison of the in Vivo Stability of 2 Cementless TKA Designs
Launched by HELSE MØRE OG ROMSDAL HF · Dec 6, 2022
Trial Information
Current as of February 05, 2025
Active, not recruiting
Keywords
ClinConnect Summary
Total joint replacement is an efficacious treatment for osteoarthritis of hips and knees. Both TKA and Total Hip Artrhoplasties (THA) have excellent implant survivorship. However, patients' satisfaction is lower in TKA than THA. A possible cause of the discrepancy is the unnatural knee kinematics after TKA. Various implants designs have been developed to solve the problem. The most common fixation mode is cemented TKA with good survival up to 15 years. However, newer series in younger patients also have shown lasting survival with cementless implants (Nilsson KG, Prudhon JL). Among various ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Patients referred to Kristiansund Hospital for primary total knee replacement surgery for osteoarthritis with Kellgren \& Lawrence grade 3 or 4
- Exclusion Criteria:
- • Preoperative severe deformity (Hip-Knee-Ankle angle of \>5 (valgus) or \<-15 degrees (varus) on a full-length leg image at weight bearing
- • Preoperative flexion contracture more than 15°
- • Less than 50 and more than 75 years of age at the time of surgery
- • Use of walking aids because of other musculoskeletal and neuromuscular problems
- • Preoperative diagnosis other than osteoarthritis or avascular necrosis (e.g. rheumatoid arthritis, tumours)
- • Revision arthroplasty
- • Obesity with BMI\>35 g/m2
- • Lateral collateral ligament deficient knee
- • Previous knee joint infection
- • Cognitive dysfunction or severe psychiatric disorders.
Trial Officials
Frank-David Øhrn, MD, PhD
Study Director
Møre og Romsdal Hospital Trust
Stephan M Röhrl, MD, PhD
Study Chair
Oslo University Hospital
About Helse Møre Og Romsdal Hf
Helse Møre og Romsdal HF is a prominent healthcare organization based in Norway, dedicated to providing high-quality medical services and advancing clinical research. As a regional health authority, it encompasses several hospitals and healthcare facilities, focusing on delivering comprehensive care while promoting innovation and evidence-based practices. The organization actively engages in clinical trials to enhance patient outcomes and contribute to the scientific community, fostering collaborations that aim to improve healthcare delivery and treatment options in various medical fields.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kristiansund, Møre And Romsdal, Norway
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials